{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:12:07Z","timestamp":1788869527735,"version":"build-2803163510"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The development of novel antibiotics is urgently needed due to the rise in\nmultidrug-resistant (MDR) infections globally. Marine microorganisms have emerged as unexplored\nsources of bioactive compounds with unique mechanisms to combat antimicrobial resistance (AMR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review summarizes peer-reviewed and recent research from PubMed, Scopus, and\nWeb of Science to evaluate the scope of marine-derived metabolites against AMR pathogens. The\nfocus was on studies describing antimicrobial metabolites produced by marine actinomycetes, bacteria,\nand fungi. Studies involving non-resistant pathogens or non-marine sources were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The review identifies various secondary metabolites, including peptides, polyketides, macrolides,\nfatty acid amines, equisetin, and aminolipids. These compounds target AMR pathogens such\nas MRSA, VRE, and VRSE. Marine actinomycetes\u2014including Streptomyces spp., Micromonospora\nspp., and Verrucosispora spp.\u2014are key producers of antimicrobial compounds. Likewise, marine\nbacterial species such as Bacillus spp., Aequorivita spp., and Zobellia galactanivorans, as well as\nfungal species like Penicillium spp. and Fusarium spp., produce bioactive compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These findings highlight the potential of marine microbes as sources of novel antibiotics.\nDespite this potential, several limitations persist, including scalability issues, the noncultivability\nof many microbes, toxicology concerns, source-dependent variability, and insufficient in\nvivo validation. These challenges can be addressed by integrating modern omics technologies to\nadvance drug discovery for AMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This review underscores marine microbes as promising sources in the fight against\nAMR. To unlock their full potential, greater interdisciplinary collaboration is needed to develop sustainable\nsolutions, accelerate antibiotic discovery, and address the global AMR crisis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501424514251130193844","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:11:21Z","timestamp":1767957081000},"page":"552-563","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Marine Microbes: A Source of Novel Antibiotics against Antimicrobial-resistant (AMR) Pathogens: A Systematic Review"],"prefix":"10.2174","volume":"27","author":[{"given":"Ishita","family":"Raninga","sequence":"first","affiliation":[{"name":"Department of Microbiology, Atmiya University, Rajkot, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Atmiya University,Rajkot, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2024","unstructured":"Antimicrobial resistance.  Available from:  https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/antimicrobial-resistance2024"},{"key":"ref=2","year":"2025","unstructured":"Antimicrobial Resistance: FDA's role in antimicrobial resistance (AMR) preparedness and response, and information about AMR.  Available from:  https:\/\/www.fda.gov\/emergency-preparedness-and- esponse\/mcm-issues\/antimicrobial-resistance2025"},{"key":"ref=3","year":"2025","unstructured":"About antimicrobial resistance investments and action.  Available from:  https:\/\/www.cdc.gov\/antimicrobial-resistance\/programs\/AR-investments.html2025"},{"key":"ref=4","year":"2022","unstructured":"Global antimicrobial resistance and use surveillance system (\u200eGLASS)\u200e report: 2022.  Available from:  https:\/\/www.who.int\/publications\/i\/ item\/97892400627022022"},{"key":"ref=5","year":"2025","unstructured":"Antimicrobial resistance threatens development, SDGs: Tripartite report.  Available from:  https:\/\/sdg.iisd.org\/news\/antimicrobial-resistance-threatens-development-sdgs-tripartite-report\/2025"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"Magiorakos A.P.","year":"2012","unstructured":"Magiorakos A.P.; Srinivasan A.; Carey R.B.; Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect  2012,18(3),268-81","journal-title":"Clin Microbiol Infect"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/md14090165","volume":"14","author":"Al-Amoudi S.","year":"2016","unstructured":"Al-Amoudi S.; Essack M.; Sim\u00f5es M.; Bioprospecting red sea coastal ecosystems for culturable microorganisms and their antimicrobial potential. Mar Drugs  2016,14(9),165","journal-title":"Mar Drugs"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","volume":"14","author":"Uddin T.M.","year":"2021","unstructured":"Uddin T.M.; Chakraborty A.J.; Khusro A.; Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J Infect Public Health  2021,14(12),1750-66","journal-title":"J Infect Public Health"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3389\/fmicb.2018.02928","volume":"9","author":"Peterson E.","year":"2018","unstructured":"Peterson E.; Kaur P.; Antibiotic resistance mechanisms in bacteria: Relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Front Microbiol  2018,9,2928","journal-title":"Front Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"C Reygaert W.","year":"2018","unstructured":"C Reygaert W.; An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol  2018,4(3),482-501","journal-title":"AIMS Microbiol"},{"key":"ref=11","year":"2024","unstructured":"WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance.  Available from:  https:\/\/www.who.int\/publications\/i\/item\/97892400934612024"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"105059","DOI":"10.1016\/j.envint.2019.105059","volume":"131","author":"Zhu Y.G.","year":"2019","unstructured":"Zhu Y.G.; Zhao Y.; Zhu D.; Soil biota, antimicrobial resistance and planetary health. Environ Int  2019,131,105059","journal-title":"Environ Int"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/antibiotics12081267","volume":"12","author":"MacNair C.R.","year":"2023","unstructured":"MacNair C.R.; Tsai C.N.; Rutherford S.T.; Tan M.W.; Returning to nature for the next generation of antimicrobial therapeutics. Antibiotics  2023,12(8),1267","journal-title":"Antibiotics"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1134\/S0006297920110073","volume":"85","author":"Stonik V.A.","year":"2020","unstructured":"Stonik V.A.; Makarieva T.N.; Shubina L.K.; Antibiotics from marine bacteria. Biochemistry  2020,85,1362-73","journal-title":"Biochemistry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/07388551.2019.1710457","volume":"40","author":"Stincone P.","year":"2020","unstructured":"Stincone P.; Brandelli A.; Marine bacteria as source of antimicrobial compounds. Crit Rev Biotechnol  2020,40(3),306-319","journal-title":"Crit Rev Biotechnol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/md19100530","volume":"19","author":"Srinivasan R.","year":"2021","unstructured":"Srinivasan R.; Kannappan A.; Shi C.; Lin X.; Marine bacterial secondary metabolites: A treasure house for structurally unique and effective antimicrobial compounds. Mar Drugs  2021,19(10),530","journal-title":"Mar Drugs"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.sjbs.2020.09.052","volume":"28","author":"Ameen F.","year":"2021","unstructured":"Ameen F.; AlNadhari S.; Al-Homaidan A.A.; Marine microorganisms as an untapped source of bioactive compounds. Saudi J Biol Sci  2021,28(1),224-31","journal-title":"Saudi J Biol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/S1473-3099(18)30777-6","volume":"19","author":"Liu M.","year":"2019","unstructured":"Liu M.; El-Hossary E.M.; Oelschlaeger T.A.; Donia M.S.; Quinn R.J.; Abdelmohsen U.R.; Potential of marine natural products against drug-resistant bacterial infections. Lancet Infect Dis  2019,19(7),e237-45","journal-title":"Lancet Infect Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/md21010050","volume":"21","author":"Wibowo J.T.","year":"2023","unstructured":"Wibowo J.T.; Bayu A.; Aryati W.D.; Secondary metabolites from marine-derived bacteria with antibiotic and antibiofilm activities against drug-resistant pathogens. Mar Drugs  2023,21(1),50","journal-title":"Mar Drugs"},{"key":"ref=20","first-page":"801","volume":"3","author":"Sharma M.","year":"2014","unstructured":"Sharma M.; Dangi P.; Choudhary M.; Actinomycetes: Source, identification, and their applications. Int J Curr Microbiol Appl Sci  2014,3(2),801-32","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12272-020-01251-0","volume":"43","author":"Wang C.","year":"2020","unstructured":"Wang C.; Lu Y.; Cao S.; Antimicrobial compounds from marine actinomycetes. Arch Pharm Res  2020,43,677-704","journal-title":"Arch Pharm Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/md19070365","volume":"19","author":"Jagannathan S.V.","year":"2021","unstructured":"Jagannathan S.V.; Manemann E.M.; Rowe S.E.; Callender M.C.; Soto W.; Marine actinomycetes, new sources of biotechnological products. Mar Drugs  2021,19(7),365","journal-title":"Mar Drugs"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1021\/np800286d","volume":"71","author":"McArthur K.A.","year":"2008","unstructured":"McArthur K.A.; Mitchell S.S.; Tsueng G.; Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J Nat Prod  2008,71(10),1732-1737","journal-title":"J Nat Prod"},{"key":"ref=24","volume":"9","author":"Nirmala B.S.","year":"2020","unstructured":"Nirmala B.S.; Antibacterial Screening of Actinomycetes isolated along the coast Bay of Bengal, Visakhapatnam. J Biol Todays World  2020,9","journal-title":"J Biol Todays World"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fmolb.2020.00023","volume":"7","author":"Kashfi R.","year":"2020","unstructured":"Kashfi R.; Kelsey C.; Gang D.J.; Call D.R.; Gang D.R.; Metabolomic diversity and identification of antibacterial activities of bacteria isolated from marine sediments in Hawai\u2019i and Puerto Rico. Front Mol Biosci  2020,7(7),23","journal-title":"Front Mol Biosci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jiph.2018.09.005","volume":"12","author":"Priyanka S.","year":"2019","unstructured":"Priyanka S.; Jayashree M.; Shivani R.; Anwesha S.; Bhaskara Rao K.V.; i A.E.; Characterisation and identification of antibacterial compound from marine actinobacteria: In vitro and in silico analysis. J Infect Public Health  2019,12(1),83-9","journal-title":"J Infect Public Health"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/md13010128","volume":"13","author":"Lacret R.","year":"2014","unstructured":"Lacret R.; Oves-Costales D.; G\u00f3mez C.; New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis. Mar Drugs  2014,13(1),128-140","journal-title":"Mar Drugs"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.3390\/md18030145","volume":"18","author":"Nweze J.","year":"2020","unstructured":"Nweze J.; Mbaoji F.; Huang G.; Li Y.; Yang D.; Zhang Y.; Antibiotics development and the potentials of marine-derived compounds to stem the tide of and protozoa. Mar Drugs  2020,18(145)","journal-title":"Mar Drugs"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.tet.2018.03.028","volume":"74","author":"Chen M.","year":"2018","unstructured":"Chen M.; Chai W.; Zhu R.; Song T.; Zhang Z.; Lian X.Y.; Streptopyrazinones A\u2212D, rare metabolites from marine-derived Streptomyces sp. ZZ446. Tetrahedron  2018,74(16),2100-6","journal-title":"Tetrahedron"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/md22080348","volume":"22","author":"Bharathi D.","year":"2024","unstructured":"Bharathi D.; Recent advances in marine-derived compounds as potent antibacterial and antifungal agents: A comprehensive review. Mar Drugs  2024,22(8),348","journal-title":"Mar Drugs"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/md16090330","volume":"16","author":"Zhang D.","year":"2018","unstructured":"Zhang D.; Shu C.; Lian X.; Zhang Z.; New antibacterial bagremycins F and G from the marine-derived streptomyces sp. ZZ745. Mar Drugs  2018,16(9),330","journal-title":"Mar Drugs"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/md13031304","volume":"13","author":"Song Y.","year":"2015","unstructured":"Song Y.; Liu G.; Li J.; Cytotoxic and antibacterial angucycline- and prodigiosin-analogues from the deep-sea derived Streptomyces sp. SCSIO 11594. Mar Drugs  2015,13(3),1304-1316","journal-title":"Mar Drugs"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14786419.2016.1169419","volume":"31","author":"Liang Y.","year":"2017","unstructured":"Liang Y.; Chen L.; Ye X.; Anjum K.; Lian X.Y.; Zhang Z.; New streptophenazines from marine Streptomyces sp. 182SMLY. Nat Prod Res  2017,31(4),411-7","journal-title":"Nat Prod Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jiph.2019.01.065","volume":"12","author":"Al-Dhabi N.A.","year":"2019","unstructured":"Al-Dhabi N.A.; Mohammed Ghilan A.K.; Esmail G.A.; Valan Arasu M.; Duraipandiyan V.; Ponmurugan K.; Bioactivity assessment of the Saudi Arabian Marine Streptomyces sp. Al-Dhabi-90, metabolic profiling and its in vitro inhibitory property against multidrug resistant and extended-spectrum beta-lactamase clinical bacterial pathogens. J Infect Public Health  2019,12(4),549-556","journal-title":"J Infect Public Health"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.tetlet.2010.09.059","volume":"52","author":"Nicolaou K.C.","year":"2011","unstructured":"Nicolaou K.C.; Simmons N.L.; Chen J.S.; Haste N.M.; Nizet V.; Total synthesis and biological evaluation of marinopyrrole A and analogs. Tetrahedron Lett  2011,52(17),2041-3","journal-title":"Tetrahedron Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/md19110618","volume":"19","author":"Ryu M.J.","year":"2021","unstructured":"Ryu M.J.; Hillman P.F.; Lee J.; Antibacterial meroterpenoids, merochlorins G\u2013J from the marine bacterium Streptomyces sp. Mar Drugs  2021,19(11),618","journal-title":"Mar Drugs"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9050252","volume":"9","author":"Kim M.C.","year":"2020","unstructured":"Kim M.C.; Cullum R.; Hebishy A.M.S.; Mersaquinone, A new tetracene derivative from the activity against methicillin-resistant. Antibiotics  2020,9(5),1-7","journal-title":"Antibiotics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"103775","DOI":"10.1016\/j.micpath.2019.103775","volume":"137","author":"Siddharth S.","year":"2019","unstructured":"Siddharth S.; Rai V R ; Isolation and characterization of bioactive compounds with antibacterial, antioxidant and enzyme inhibitory activities from marine-derived rare actinobacteria, Nocardiopsis sp. SCA21. Microb Pathog  2019,137,103775","journal-title":"Microb Pathog"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1021\/acs.jnatprod.6b00175","volume":"79","author":"Zhang H.","year":"2016","unstructured":"Zhang H.; Saurav K.; Yu Z.; \u03b1-pyrones with diverse hydroxy substitutions from three marine-derived nocardiopsis strains. J Nat Prod  2016,79(6),1610-8","journal-title":"J Nat Prod"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-319-69075-9_3","author":"Ancheeva E.","year":"2018","unstructured":"Ancheeva E.; El-Neketi M.; Daletos G.; Anti-infective compounds from marine organisms. Grand Challenges in Marine Biotechnology Grand Challenges in Biology and Biotechnology  2018,97-155","journal-title":"Grand Challenges in Marine Biotechnology Grand Challenges in Biology and Biotechnology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/md16030095","volume":"16","author":"P\u00e9rez-Bonilla M.","year":"2018","unstructured":"P\u00e9rez-Bonilla M.; Oves-Costales D.; Cruz M.D.; Phocoenamicins B and C, new antibacterial spirotetronates isolated from a marine Micromonospora sp. Mar Drugs  2018,16(3),95","journal-title":"Mar Drugs"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1038\/s41598-020-60677-0","volume":"10","author":"Fu G.","year":"2020","unstructured":"Fu G.; Wang R.; Ding J.; Micromonospora zhangzhouensis sp. nov., a novel actinobacterium isolated from mangrove Soil, exerts a cytotoxic activity in vitro. Sci Rep  2020,10(1),3889","journal-title":"Sci Rep"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1128\/jb.05041-11","volume":"193","author":"Roh H.","year":"2011","unstructured":"Roh H.; Uguru G.C.; Ko H.J.; Genome sequence of the abyssomicin- and proximicin-producing marine actinomycete Verrucosispora maris AB-18-032. J Bacteriol  2011,193(13)","journal-title":"J Bacteriol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1021\/ja0558948","volume":"128","author":"Kwon H.C.","year":"2006","unstructured":"Kwon H.C.; Kauffman C.A.; Jensen P.R.; Fenical W.; Marinomycins A.; Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus \"marinispora\". J Am Chem Soc  2006,128(5),1622-32","journal-title":"J Am Chem Soc"},{"key":"ref=45","first-page":"800","volume":"3","author":"Ganapathi J.","year":"2015","unstructured":"Ganapathi J.; Ganatra B.S.; Jayanthi G.; Isolation and screening of marine bacteria and actinomycetes for enzyme production and antibacterial activity from Vadinar coast, Jamnagar, Gulf of Kachchh. Curr Res Microbiol Biotechnol  2015,3(6),800-4","journal-title":"Curr Res Microbiol Biotechnol"},{"key":"ref=46","first-page":"121","volume":"5","author":"El A.","year":"2011","unstructured":"El A.; Hosny D.M.S.; Sheir D.H.; Eldewany A.I.; Production of antimicrobial agent from marine bacteria isolated from mediterranean.  2011,5(5),121-8"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.micpath.2018.08.014","volume":"124","author":"Lotfy W.A.","year":"2018","unstructured":"Lotfy W.A.; Mostafa S.W.; Adel A.A.; Ghanem K.M.; Production of di-(2-ethylhexyl) phthalate by Bacillus subtilis AD35: Isolation, purification, characterization and biological activities. Microb Pathog  2018,124,89-100","journal-title":"Microb Pathog"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.2147\/DMSO.S435062","volume":"16","author":"Li Z.","year":"2023","unstructured":"Li Z.; Li T.; Tang J.; Antibacterial activity of surfactin and synergistic effect with conventional antibiotics against methicillin-resistant Staphylococcus aureus isolated from patients with diabetic foot ulcers. Diabetes Metab Syndr Obes  2023,16(December),3727-3737","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/20477724.2017.1390829","volume":"111","author":"Arul D.","year":"2017","unstructured":"Arul D.; Balasubramani G.; Balasubramanian V.; Natarajan T.; Perumal P.; Antibacterial efficacy of silver nanoparticles and ethyl acetate\u2019s metabolites of the potent halophilic (marine) bacterium, Bacillus cereus A30 on multidrug resistant bacteria. Pathog Glob Health  2017,111(7),367-82","journal-title":"Pathog Glob Health"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/md16060187","volume":"16","author":"Chianese G.","year":"2018","unstructured":"Chianese G.; Esposito F.P.; Parrot D.; Ingham C.; De Pascale D.; Tasdemir D.; Linear aminolipids with moderate antimicrobial activity from the antarctic gram-negative bacterium Aequorivita sp. Mar Drugs  2018,16(6),187","journal-title":"Mar Drugs"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1021\/jacs.1c02622","volume":"143","author":"Johnson R.A.","year":"2021","unstructured":"Johnson R.A.; Chan A.N.; Ward R.D.; Inhibition of isoleucyl-tRNA synthetase by the hybrid antibiotic thiomarinol. J Am Chem Soc  2021,143(31),12003-12013","journal-title":"J Am Chem Soc"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10482-017-0839-1","volume":"110","author":"Kalinovskaya N.I.","year":"2017","unstructured":"Kalinovskaya N.I.; Romanenko L.A.; Kalinovsky A.I.; Antibacterial low-molecular-weight compounds produced by the marine bacterium Rheinheimera japonica KMM 9513T. Antonie van Leeuwenhoek  2017,110,719-26","journal-title":"Antonie van Leeuwenhoek"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/antibiotics9060340","volume":"9","author":"Willems T.","year":"2020","unstructured":"Willems T.; De Mol M.L.; De Bruycker A.; De Maeseneire S.L.; Soetaert W.K.; Alkaloids from marine fungi: Promising antimicrobials. Antibiotics  2020,9(6),340","journal-title":"Antibiotics"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"151504","DOI":"10.1016\/j.tetlet.2019.151504","volume":"61","author":"Ma M.","year":"2020","unstructured":"Ma M.; Ge H.; Yi W.; Wu B.; Zhang Z.; Bioactive drimane sesquiterpenoids and isocoumarins from the marine-derived fungus Penicillium minioluteum ZZ1657. Tetrahedron Lett  2020,61(7),151504","journal-title":"Tetrahedron Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/md17010046","volume":"17","author":"Wang W.","year":"2019","unstructured":"Wang W.; Liao Y.; Zhang B.; Citrinin monomer and dimer derivatives with antibacterial and cytotoxic activities isolated from the deep sea-derived fungus Penicillium citrinum NLG-S01-P1. Mar Drugs  2019,17(1),46","journal-title":"Mar Drugs"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1021\/acs.jafc.1c01148","volume":"69","author":"Lin L.B.","year":"2021","unstructured":"Lin L.B.; Gao Y.Q.; Han R.; Alkylated salicylaldehydes and prenylated indole alkaloids from the endolichenic fungus Aspergillus chevalieri and their bioactivities. J Agric Food Chem  2021,69(23),6524-34","journal-title":"J Agric Food Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cej.2018.05.159","volume":"350","author":"Luo M.","year":"2018","unstructured":"Luo M.; Ming Y.; Wang L.; Local delivery of deep marine fungus-derived equisetin from polyvinylpyrrolidone (PVP) nanofibers for anti-MRSA activity. Chem Eng J  2018,350(May),157-63","journal-title":"Chem Eng J"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"10197","DOI":"10.1039\/D0RA00894J","volume":"10","author":"Chen C.","year":"2020","unstructured":"Chen C.; Tao H.; Chen W.; Recent advances in the chemistry and biology of azaphilones. RSC Advances  2020,10(17),10197-220","journal-title":"RSC Advances"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/biom13071021","volume":"13","author":"Nicoletti R.","year":"2023","unstructured":"Nicoletti R.; Bellavita R.; Falanga A.; The outstanding chemodiversity of marine-derived Talaromyces. Biomolecules  2023,13(7),1021","journal-title":"Biomolecules"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.micres.2012.06.005","volume":"167","author":"Subramani R.","year":"2012","unstructured":"Subramani R.; Aalbersberg W.; Marine actinomycetes: An ongoing source of novel bioactive metabolites. Microbiol Res  2012,167(10),571-80","journal-title":"Microbiol Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1021\/acssynbio.5b00038","volume":"4","author":"Tong Y.","year":"2015","unstructured":"Tong Y.; Charusanti P.; Zhang L.; Weber T.; Lee S.Y.; CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synth Biol  2015,4(9),1020-1029","journal-title":"ACS Synth Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"DiMasi J.A.","year":"2016","unstructured":"DiMasi J.A.; Grabowski H.G.; Hansen R.W.; Innovation in the pharmaceutical industry: New estimates of RandD costs. J Health Econ  2016,47,20-33","journal-title":"J Health Econ"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/COC.0b013e318199fb6e","volume":"33","author":"Le Tourneau C.","year":"2010","unstructured":"Le Tourneau C.; Faivre S.; Ciruelos E.; Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma. Am J Clin Oncol  2010,33(2),132-6","journal-title":"Am J Clin Oncol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"Vamathevan J.","year":"2019","unstructured":"Vamathevan J.; Clark D.; Czodrowski P.; Applications of machine learning in drug discovery and development. Nat Rev Drug Discov  2019,18(6),463-77","journal-title":"Nat Rev Drug Discov"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1039\/b808331m","volume":"26","author":"Cuevas C.","year":"2009","unstructured":"Cuevas C.; Francesch A.; Development of Yondelis\u00ae (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat Prod Rep  2009,26(3),322-337","journal-title":"Nat Prod Rep"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"Ling L.L.","year":"2015","unstructured":"Ling L.L.; Schneider T.; Peoples A.J.; A new antibiotic kills pathogens without detectable resistance. Nature  2015,517(7535),455-459","journal-title":"Nature"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1128\/AEM.01754-09","volume":"76","author":"Nichols D.","year":"2010","unstructured":"Nichols D.; Cahoon N.; Trakhtenberg E.M.; Use of ichip for high-throughput in situ cultivation of \u201cuncultivable\u201d microbial species. Appl Environ Microbiol  2010,76(8),2445-50","journal-title":"Appl Environ Microbiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1128\/JB.00345-12","volume":"194","author":"Stewart E.J.","year":"2012","unstructured":"Stewart E.J.; Growing unculturable bacteria. J Bacteriol  2012,194(16),4151-60","journal-title":"J Bacteriol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s43705-023-00310-z","volume":"3","author":"Pe\u00f1a-Montenegro T.D.","year":"2023","unstructured":"Pe\u00f1a-Montenegro T.D.; Kleindienst S.; Allen A.E.; Species-specific responses of marine bacteria to environmental perturbation. ISME Commun  2023,3(1),99","journal-title":"ISME Commun"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00300-018-2300-y","volume":"41","author":"Silva T.R.","year":"2018","unstructured":"Silva T.R.; Duarte A.W.F.; Passarini M.R.Z.; Bacteria from Antarctic environments: Diversity and detection of antimicrobial, antiproliferative, and antiparasitic activities. Polar Biol  2018,41(7),1505-1519","journal-title":"Polar Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1039\/D2NP00083K","volume":"40","author":"Carroll A.R.","year":"2023","unstructured":"Carroll A.R.; Copp B.R.; Davis R.A.; Keyzers R.A.; Prinsep M.R.; Marine natural products. Nat Prod Rep  2023,40(2),275-325","journal-title":"Nat Prod Rep"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"Newman D.J.","year":"2020","unstructured":"Newman D.J.; Cragg G.M.; Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod  2020,83(3),770-803","journal-title":"J Nat Prod"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11306-016-1087-5","volume":"12","author":"Floros D.J.","year":"2016","unstructured":"Floros D.J.; Jensen P.R.; Dorrestein P.C.; Koyama N.; A metabolomics guided exploration of marine natural product chemical space. Metabolomics  2016,12(9),145","journal-title":"Metabolomics"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"629629","DOI":"10.3389\/fmars.2021.629629","volume":"8","author":"Rotter A.","year":"2021","unstructured":"Rotter A.; Barbier M.; Bertoni F.; The essentials of marine biotechnology. Front Mar Sci  2021,8,629629","journal-title":"Front Mar Sci"},{"key":"ref=75","year":"2025","unstructured":"Healthcare-associated infections.  Available from:  https:\/\/www.ecdc.europa.eu\/en\/healthcare-associated-infections2025"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/ijmr.IJMR_331_18","volume":"149","author":"Taneja N.","year":"2019","unstructured":"Taneja N.; Sharma M.; Antimicrobial resistance in the environment. Indian J Med Res  2019,149(2),119-128","journal-title":"Indian J Med Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"29078","DOI":"10.1039\/D2RA04884A","volume":"12","author":"Elmaidomy A.H.","year":"2022","unstructured":"Elmaidomy A.H.; Shady N.H.; Abdeljawad K.M.; Antimicrobial potentials of natural products against multidrug resistance pathogens: A comprehensive review. RSC Advances  2022,12(45),29078-29102","journal-title":"RSC Advances"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"206","DOI":"10.18502\/ajmb.v14i3.9827","volume":"14","author":"Chbel A.","year":"2022","unstructured":"Chbel A.; Rodriguez-Castro J.; Quinteiro J.; Isolation, molecular identification and antibacterial potential of marine bacteria from deep Atlantic Ocean of Morocco. Avicenna J Med Biotechnol  2022,14(3),206-15","journal-title":"Avicenna J Med Biotechnol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/microorganisms10122468","volume":"10","author":"Ruginescu R.","year":"2022","unstructured":"Ruginescu R.; Lavin P.; Iancu L.; Menabit S.; Purcarea C.; Bioprospecting for novel bacterial sources of hydrolytic enzymes and antimicrobials in the Romanian Littoral Zone of the Black Sea. Microorganisms  2022,10(12),2468","journal-title":"Microorganisms"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"17837","DOI":"10.1039\/C8RA01267A","volume":"8","author":"Kiran G.S.","year":"2018","unstructured":"Kiran G.S.; Priyadharsini S.; Sajayan A.; Ravindran A.; Selvin J.; An antibiotic agent pyrrolo [1, 2-a] pyrazine-1, 4-dione, hexahydro isolated from a marine bacterium Bacillus tequilensis MSI45 effectively controls multi-drug resistant Staphylococcus aureus. RSC Adv  2018,8(32),17837-46","journal-title":"RSC Adv"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/life13051073","volume":"13","author":"Baranova A.A.","year":"2023","unstructured":"Baranova A.A.; Alferova V.A.; Korshun V.A.; Tyurin A.P.; Modern trends in natural antibiotic discovery. Life  2023,13(5),1073","journal-title":"Life"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501424514251130193844","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249144\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501424514251130193844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:42:34Z","timestamp":1788867754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249144\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501424514251130193844","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}